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Regulatory Functions of 
α-Amylase in the Small Intestine 
Other than Starch Digestion: 
α-Glucosidase Activity, Glucose 
Absorption, Cell Proliferation, 
and Differentiation
Kimie Date
Abstract
Pancreatic α-amylase binds to the N-glycan of glycoproteins. Here, I will show 
that pancreatic α-amylase has regulatory functions in the small intestine other than 
starch digestion. These new functions were revealed by identification of α-amylase-
binding proteins in the intestinal brush border membrane (BBM). This topic will 
include the following four parts: 1) identification of glycoproteins that bind pan-
creatic α-amylase in the small intestinal BBM; 2) interactions between pancreatic 
α-amylase and the binding glycoproteins, sucrose-isomaltase (α-glucosidase), and 
sodium/glucose co-transporter 1 (SGLT1), in which pancreatic α-amylase enhanced 
maltose degradation of sucrose-isomaltase under conditions including calcium 
and sodium, and inhibited glucose uptake of SGLT1; 3) localization of pancreatic 
α-amylase in the small intestine by binding to the BBM and being internalized 
into lysosomes through the endocytic pathway; and 4) expression of endogenous 
α-amylase in the duodenum: AMY2B, a pancreatic type α-amylase, is highly 
expressed in the human duodenum next to the pancreas. The α-amylase expression 
in the duodenum is required for proliferation and differentiation of human small 
intestinal epithelial cells.
Keywords: pancreatic α-amylase, small intestine, sucrase-isomaltase, SGLT1,  
cell proliferation, cell differentiation, endocytosis
1. Introduction
α-Amylase has been found in many organisms, including bacteria, mainly 
Bacilli, seeds of cereals and legumes, and digestive glands of animals such as 
humans and pigs. These α-amylases can be obtained as homogeneous preparations 
and utilized in various situations. For example, mammalian α-amylase is used as a 
gastrointestinal medicine and digestive agent. Microbial α-amylase is used in sugar 
production, food processing, clothing production, and detergents because it can be 
produced on an industrial scale. The uses of these amylases all focus on the ability of 
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the amylase to degrade polysaccharides. The α-amylase in pancreatic juice and saliva 
clearly functions as a digestive enzyme. It is an endo-type enzyme that randomly 
cleaves α-1,4 glycosidic bonds such as starch and glycogen to produce maltose and 
oligosaccharides [1]. Therefore, α-amylase in digestive juices is an essential enzyme 
for animals consuming a starch diet. α-Amylase has been found in liver [2], brain 
[3], blood, urine, and cancer cells [4] in humans, but its physiological significance 
has not been completely elucidated yet.
It has been reported that porcine pancreatic α-amylase binds to an N-linked 
glycan of glycoproteins [5]. It has been shown that the binding of porcine pancre-
atic α-amylase to N-linked glycans is different from that of the polysaccharide as a 
substrate. It shows that the carbohydrate-binding activities of pancreatic α-amylase 
are not common to all types of α-amylase. α-Amylases from barley, Bacillus subtilis, 
and mammalian saliva do not have this activity. Porcine pancreatic α-amylase binds 
mainly to transferrin having complex-type biantennary N-glycans, fetuin having 
complex-type triantennary N-glycans, and ribonuclease B having high-mannose 
N-glycans. However, it does not bind to bovine submandibular gland mucin having 
O-glycans or bovine serum albumin having no sugar chains. The carbohydrate-
binding activities of porcine pancreatic α-amylase are affected by pH. Porcine 
pancreatic α-amylase has a high affinity for both complex type and high-mannose 
N-glycans under pH 5.5. On the other hand, the binding activity is seen with only 
the high-mannose N-glycans, and the binding to the complex N-glycans is reduced 
under neutral pH. Thus, pancreatic α-amylase selectively recognizes the structure 
of N-glycans of glycoproteins depending on pH.
The biological significance of the N-glycan binding found in pancreatic 
α-amylase in vivo is unknown. Pancreatic α-amylase is synthesized in pancreatic 
acinar cells, packed into acidic zymogen granules (pH 5.5), and secreted into 
alkaline pancreatic juice (pH 8.0) [6]. Pancreatic juice flows into the duodenum 
and mixes with gastric acid where it is neutralized, and pancreatic α-amylase exerts 
its enzymatic activity. The pH in the middle of the duodenum falls from pH 6.5 to 
4.5 in a 3-hour period after a meal [7]. There are glycoproteins with N-glycans in 
pancreatic zymogen granules, its membrane, and the lumen of the small intestine 
[8–11]. These suggest that the N-glycan-binding activity of pancreatic α-amylase 
may be play a role in the packing of pancreatic zymogen granules, its exocytosis in 
the pancreas, and digestion and absorption of carbohydrates in the small intestine.
In this study, we elucidated the roles of the N-glycan-binding activity of pan-
creatic α-amylase in the small intestine by identifying the glycoproteins to which 
the α-amylase binds on the small intestinal brush border membrane (BBM), the 
luminal surface of the small intestine where many glycoproteins are located. The 
functions and localizations of the identified α-amylase-binding-glycoproteins and 
analyses of interactions between α-amylase and the glycoproteins revealed that pan-
creatic α-amylase has the following regulatory functions other than as a digestive 
enzyme: (1) enhancement of α-glucosidase, sucrase-isomaltase, (2) regulation of 
sodium-dependent glucose uptake, and (3) localization of pancreatic α-amylase in 
the small intestine. Furthermore, the new discoveries show that duodenal epithelial 
cells express α-amylase, which is essential for proliferation and differentiation of 
small intestinal epithelial cells.
2.  Identification of glycoproteins that bind pancreatic α-amylase in the 
small intestinal BBM
In the small intestine, epithelial cells in the luminal villi have a brush border on 
the surface, and alkaline phosphatase and other membrane-type digestive enzymes 
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are localized on the BBM. The BBM is covered with a glycocalyx composed of 
glycoproteins and proteoglycans [10, 12]. Lectin staining of rat small intestine tis-
sue revealed that rat small intestinal BBM expresses glycoproteins having complex, 
high-mannose N-glycans, and core 1 O-glycans including NeuAcα2-6Gal/GalNAc, 
and Galβ1-3Gal [9]. It is reported that N-glycans of glycoproteins on the surface of 
porcine intestine have more complex types than those on the rats [13].
Previous reports have shown that pancreatic α-amylase binds to the N-glycans of 
purified glycoproteins [5], but it has not been confirmed whether or not pancreatic 
α-amylase binds to glycoproteins on small intestinal BBM. Furthermore, which 
glycoproteins bind to the pancreatic α-amylase and what role they play in interac-
tions with the α-amylase were unknown. This study demonstrated the binding 
of α-amylase to pig small intestinal BBM by immunostaining, and identified the 
glycoproteins that bind α-amylase in the pig small intestinal BBM [14].
2.1 Binding of pancreatic α-amylase to small intestinal BBM
Tissue sections of pig duodenum were immunostained with an anti-pancreatic 
α-amylase antibody. Entire duodenal tissue sections were stained with the pancre-
atic α-amylase antibody when there was a large amount of food in the stomach (dur-
ing non-fasting), but hardly stained when there was little in the stomach (during 
fasting) [14]. The localization of exogenous pancreatic α-amylase was examined 
by staining a 1-cm section of the duodenum of a fasted pig with the pancreatic 
α-amylase antibody. Tissue sections fixed in formalin and embedded in paraffin 
were immunostained to detect pancreatic α-amylase. The duodenal sections were 
agitated in pancreatic α-amylase solution at 4°C. As a result, pancreatic α-amylase 
bound to the BBM, which is the upper end of the duodenal epithelium (Figure 1), 
and α-amylase staining increased in a time-dependent manner with agitation. 
Mannan inhibited the binding of pancreatic α-amylase to BBM duodenum sections 
incubated in α-amylase solution for 30 min. On the other hand, galactan and colo-
minic acid inhibited binding of α-amylase to BBM after 10 min of agitation, but did 
not inhibit binding of α-amylase to BBM agitated for 30 min (data not shown) [14]. 
Pancreatic α-amylase bound to duodenum BBM, and its binding was inhibited by 
Figure 1. 
Binding of pancreatic α-amylase to pig duodenum BBM.
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mannan, indicating that α-amylase binds to duodenal BBM in a mannose-specific 
manner, even at the tissue level.
One-centimeter duodenum sections from fasted pigs were incubated with 
pancreatic α-amylase (10 μM) in PBS (pH 7.2) including phenylmethylsulfonyl 
fluoride (final concentratation 1 mM) at 4°C for 30 min, then fixed and paraffin-
embedded. The paraffin sections were immunostained with rabbit anti-α-amylase 
IgGs-HRP. The color was developed with DAB/H2O2 and then counterstained with 
hematoxylin.
2.2  Separation and identification of glycoproteins from the small intestinal 
BBM that bind pancreatic α-amylase
It was shown that pig duodenal BBM contains glycoproteins that bind to 
pancreatic α-amylase having high mannose-type and complex-type N-glycans. 
Therefore, we separated and identified the glycoproteins binding α-amylase 
from fasted pig duodenal BBM [14]. The binding glycoproteins were separated 
from BBM solubilized with 1% TritonX-100 by using affinity chromatography 
with an α-amylase-Sepharose 6B column. The α-amylase-binding fractions were 
eluted by methyl-D-mannopyranoside and separated by molecular weight using 
SDS-PAGE. Seven main bands stained by SYPRO Ruby protein staining were cut 
out, treated with pepsin, and analyzed by LC–MS/MS for identification of the 
proteins in the bands. The major α-amylase-binding glycoproteins identified 
are shown in Table 1. The binding glycoproteins were grouped by functions 
and localizations. Group 1 consisted of membrane glycoproteins involved in 
α-glucosidase and sugar absorption, which function in glucose assimilation 
after starch digestion by α-amylase in the small intestine. Groups 2 and 3 
consisted of membrane glycoproteins involved in transcytosis and proteolysis, 
respectively.
All seven bands were stained by lectins with ConA, GNA, and L-PHA, indicat-
ing the presence of N-glycans. ConA (concanavalin A), GNA (snowdrop lectin), 
and L-PHA (Phaseolus vulgaris lectin type L) bind specifically to N-glycans, high-
mannose structures, and complex-type N-glycans, respectively. The identification 
of these α-amylase-binding proteins indicates that the N-glycan-binding activity 
Identified proteins
MW (kDa) Group 1 Group 2 Group 3
202 SGLT1, SI
144–156 VLA-2 Aminopeptidases, Enterokinase
110–122 SGLT1 DPP-IV, Integrin β1, ACE2 DPP-IV
99 Aminopeptidases
78 SGLT1 Transferrin, Transferrin 
receptor
50–57 SGLT1 Na+/K+-ATPase β1-subunit Enterokinase Amine oxidase B
46 Epoxide 
hydrase
CD Man-6-P receptor, 
Aminopeptidase N
Aminopeptidase N
SGLT1, sodium glucose co-transporter 1; SI, sucrose-isomaltase; VLA-2, integrin very late antigen-2; DPP-IV, 
dipeptidylpeptidase IV; ACE 2, angiotensin-converting enzyme 2.
Table 1. 
Identification of α-amylase-binding proteins in intestinal BBM.
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of pancreatic α-amylase in the duodenum may play a regulatory role involved in 
α-glucosidase/sugar absorption, transcytosis, and proteolysis.
3.  Interaction between pancreatic α-amylase and binding glycoproteins 
in small intestinal BBM
First, effects of pancreatic α-amylase on the activities of glycoproteins in Group 
1 were investigated. Group 1 consists of SI and SGLT1. SI, a membrane glycopro-
tein, digests sucrose, isomaltose, and maltose on the membrane as α-glucosidases. 
SGLT1 is also a membrane glycoprotein and plays an essential role in glucose 
absorption in the small intestine.
3.1 Effects of pancreatic α-amylase on α-glucosidase activity
SI plays an important role in the end digestion of starch because SI breaks down 
the maltose produced by α-amylase from starch into glucose as an α-glucosidase on 
the small intestinal membrane. SI is essential for the end digestion of starch, and its 
Figure 2. 
Effects of pancreatic α-amylase and ConA on maltose- and sucrose-degrading activity of pig duodenum 
BBM vesicles. A BBM vesicle suspension (50 μl) was pre-incubated with various concentrations of pancreatic 
α-amylase or ConA (0–50 μM) for 15 min at 37°C, and incubated with 0.056 M maltose (left) or 0.056 M 
sucrose (right) as substrate (50 μl) for 30 min (left) or 60 min (right) at 37°C. The maltose or sucrose 
hydrolysis was measured in the presence of 5 mM CaCl2 and 0.15 M NaCl (upper) or in the absence of CaCl2 
and NaCl (lower). Phlorizin (0.5 mM), a glucose transporter inhibitor, was included in the substrate solution. 
The degrading activity by the production of glucose was measured using a glucose C-II test Wako (Wako, 
FUJIFILM). ●: α-amylase, ○: ConA. Results are given as means±SE; n = 6. *p < 0.05; **p < 0.01 compared with 
the absence of α-amylase or ConA by Student’s t-test [14].
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deficiency and remarkable fluctuations in enzymatic activity are thought to have a 
significant effect on starch digestion and glucose absorption. In this study, a method 
was established for measuring SI activity using BBM that evaluates the effects of 
pancreatic α-amylase on SI activity as an α-glucosidase [14].
The effect of pancreatic α-amylase on SI activity was investigated with and with-
out CaCl2 and NaCl. As a comparison with α-amylase, the effects of concanavalin 
A (ConA), a lectin that recognizes α-mannose and α-glucose, were also measured 
because α-amylase shows a high affinity to α-mannose. In maltose degradation 
activity by SI, the α-amylase showed enhanced activity only in the presence of 
5 mM CaCl2 and 0.15 M NaCl, while no effect of α-amylase was shown in the 
absence of CaCl2 and NaCl (Figure 2, left). ConA had no effect on the maltose 
degradation activity by SI. On the other hand, α-amylase did not affect the sucrose 
degradation activity, and ConA inhibited it by about 20% in the presence and 
absence of 5 mM CaCl2 and 0.15 M NaCl, respectively (Figure 2, right).
3.2 Effects of pancreatic α-amylase on SGLT1 activity
SGLT1 is a glycoprotein having a complex-type N-glycan and a sodium-
dependent glucose transporter indispensable for glucose absorption in the small 
intestine. The effect on the SGLT1 activity means that it directly affects the blood 
glucose concentration. This study shows the results of examining whether pancre-
atic α-amylase affects SGLT1 activity.
First, the timing of the addition of pancreatic α-amylase, where the effect of 
the α-amylase on SGLT1 activity is most frequently observed, was examined. T1: 
Figure 3. 
Effects of pancreaitc α-amylase on Na+-dependent glucose uptake. SGLT1 activity was assayed as Na+-
dependent [14C]-D-glucose uptake (0.2 mM) in BBM vesicles prepared from pig duodenum. (A) Schematic 
illustration of the SGLT1 activity measurement system using BBM vesicles. (B) Timing of the α-amylase 
addition to the SGLT1 activity measurement system. T1: α-amylase was added to BBM vesicles prior to 
[14C]-D-glucose; T2: α-amylase was pre-incubated with BBM vesicles 2 min before addition of [14C]-D-glucose; 
T3: α-amylase was pre-incubated for 15 min with [14C]-D-glucose. □: Without pancreatic α-amylase (control), 
■: With pancreatic α-amylase (10 μM). (C) Effects of pancreatic α-amylase on SGLT1 acrtivity under 
the three conditions. (D) Dose dependency of D-glucose (D-Glc) uptake on final concentrations of added 
α-amylase (μM). Pancreatic α-amylase was added at T1. Results are given as means ±SE; n = 6. *p < 0.05, 
***p < 0.001 compared with the absence of polysaccharide by Student’s t-test [14].
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Pancreatic α-amylase was added just before the [14C]-D-glucose substrate solution 
without preincubation. T2: The α-amylase was pre-incubated with BBM vesicle 
solution at 37°C for 2 min. T3: The α-amylase was pre-incubated with [14C]-D-
glucose substrate solution at 37°C for 15 min (Figure 3A and B). Inhibition of 
SGLT1 acitivity by pancreatic α-amylase was shown at all tested additions of the 
α-amylase, and T1 was the most efficient for SGLT1 inhibition (Figure 3C). The 
concentration-dependent effects of α-amylase on SGLT1 activity were examined 
under the T1 condition. SGLT1 activity was reduced from 5 μM of α-amylase, and 
inhibited to 34% at 10 μM and 10% at 20 μM (Figure 3D). The 50% inhibitory 
concentration (IC50) value was 8.1 μM.
Pancreatic α-amylase concentrations in pancreatic juice have been reported to be 
4.2 mg/ml in pigs and 5–16 mg/ml in cows [15, 16]. Humans secrete 1–3 L of pancre-
atic juice containing several to several tens of grams of protein per day. Therefore, 
pancreatic α-amylase is probably present in the order of mg/ml because the total 
concentration of α-amylase in pancreatic juice protein is 26.5% [17]. In this study, it 
was found that SGLT1 activity was inhibited by pancreatic α-amylase at more than 
10 μM (≒ 0.56 mg/ml).
4. Localization of pancreatic α-amylase in the small intestine
α-Amylase synthesized in the pancreas and salivary glands is mostly secreted 
into the gastrointestinal tract where it digests starch. Part of the α-amylase enters 
the blood, one-quarter of which is excreted from the kidneys into the urine, and 
the remaining α-amylase is degraded (inactivated) by an unknown pathway. The 
α-amylase in the blood is maintained at a constant level by supply from the pancreas 
and salivary glands, excretion outside the body, and decomposition in the body. 
Therefore, the blood α-amylase activity is used for diagnosing pancreatitis and 
other diseases. The proportion of pancreatic α-amylase (unglycosylated 54 kDa) 
and saliva α-amylase (unglycosylated 54 kDa and glycosylated 57 kDa) is same 
when the concentration of α-amylase in human blood is examined by electropho-
resis. When the pancrea is completely removed due to pancreatic cancer, the blood 
α-amylase activity temporarily decreases, but it returns to a normal level because 
the α-amylase in salivary glands increases. It is reported that fluorescently labeled 
α-amylase injected into rat small intestine was detected in intestinal epithelium and 
blood, indicating that the pancreatic α-amylase was transported into small intestine 
tissue (endocytosis) and blood (exocytosis) [18].
The pancreatic α-amylase-binding glycoproteins identified as Group 2 in Section 
2.2 contain membrane glycoproteins that have an endocytic function. Transferrin 
receptor (TfR) binds to iron-bound transferrin and endocytoses iron-bound trans-
ferrin into enterocytes [19]. Similarly, aminopeptidase N, ACE2, and VLA- 2 bind to 
human coronavirus [20, 21], severe acute respiratory syndrome (SARS) virus [22], 
and matrix glycoproteins [23], respectively. Further, these ligands including viruses 
are able to endocytose into enterocytes. Mannose 6-phosphate receptor (Man-6-P-
receptor) transports binding proteins to the lysosomal system [24]. DPP-IV does 
not stay in the BBM, and is transported into cells via the same pathway as amino-
peptidase N and transferrin (51). This study demonstrated an endocytic pathway 
for α-amylase secreted into the duodenum from the pancreas [25].
4.1 Endocytosis of pancreatic α-amylase into the small intestine
Two kinds of experiments were performed using pig duodenum tissues 
and Caco-2 human intestinal epithelial cells that had differentiated into small 
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intestine-like cells by culture in Transwells for 3 weeks. In the experiment using 
pig duodenum tissue, fasted duodenum with no stomach contents was cut into 
1-cm pieces and agitated in a pig pancreatic α-amylase solution at 37°C. After 
agitation for various periods of time, the tissues were fixed with formalin, and 
paraffin-embedded sections were prepared. The sections were immunofluores-
cently stained with an anti-pancreatic α-amylase antibody to clarify the localization 
of the α-amylase. No staining was detected in the tissue sections after incubation 
for 0 min. The green fluorescence with anti-pancreatic α-amylase antibody was 
detected at the upper end of the duodenum corresponding to the BBM in the 
sections incubated with α-amylase for 10 min, and α-amylase was detected in the 
entire duodenal tissue incubation for 30 min (Figure 4A). In the experiment using 
differentiated Caco-2 cells, AlexaFluor488-labeled human pancreatic α-amylase 
was added to the culture medium. After incubation for 30 min at 4°C, the α-amylase 
in the medium was washed out, and chased for 0–60 min at 37°C in fresh medium 
without α-amylase. The cells were fixed with formalin, and AlexaFluor488-labeled 
α-amylase was detected by confocal microscopy. Green fluorescence indicating the 
localization of α-amylase was detected on the cell membrane only after incuba-
tion at 4°C for 30 min. In the subsequent 37°C chase, the α-amylase was detected 
as punctates in the cells and had decreased at 60 min (Figure 4B). These results 
Figure 4. 
Incorporation of pancreatic α-amylase into pig duodenum tissue (A) and differentiated human epithelial 
cells Caco-2 (B). (A) One-centimeter duodenum sections from fasted pigs were incubated with pig pancreatic 
α-amylase (10 μM) in PBS (pH 7.2) including phenylmethylsulfonyl fluoride (final 0.1 mM) at 37°C for 
0, 10, or 30 min. The duodenum sections were fixed and paraffin-embedded. The paraffin sections were 
immunostained with rabbit anti-pancreatic α-amylase antibody as a first antibody and Alexa Fluor 488-goat 
anti-rabbit antibody. The green fluorescence was detected by a microscope (Olympus FSX100). (B) Caco-2 cells 
were seeded at 2.6 × 105 cells/cm2 on polyester Transwell permeable supports (0.4-μm pores, 12-mm diameter), 
and cultured for about 3 weeks in minimal essential medium (DMEM, Sigma) supplemented with 20% heat-
inactivated (56°C, 30 min) fetal bovine serum (FBS, Gibco) and 0.1 mM non-essential amino acids (NEAA, 
Gibco) under a 95% air and 5% CO2 atmosphere. The cells were starved in a DMEM-NEAA medium without 
FBS for 18 h. After being washed with Dulbecco’s Phosphate-Buffered Saline (DPBS) with Ca2+ and Mg2+, 
Alexa Fluor 488-human pancreatic α-amylase (20 μg/ml) in a DMEM-NEAA medium without FBS was 
added and incubated at 4°C for 30 min. The α-amylase was washed out, and cultured in DMEM including 
in 20% FBS and 1 mM NEAA at 37°C for 0–60 min. The cells were fixed, and Alexa Fluor 488-human 
pancreatic α-amylase was detected by confocal microscopy (ZEISS, LSM710). The nucleus was stained by 
4′,6-diamidino-2-phenylindole (DAPI) [25].
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indicate that pancreatic α-amylase is incorporated into duodenal tissue and small 
intestinal epithelial cells in a time- and temperature-dependent manner.
4.2 Endocytosis pathway of pancreatic α-amylase to lysosomes
The results in Figure 4B showed that pancreatic α-amylase was internal-
ized into the epithelial cells and disappeared. The cause of this disappearance 
is expected to be proteolysis. Among the α-amylase-binding proteins identified 
in Section 2.2, the membrane glycoprotein proteins classified into Group 3 are 
involved in protein degradation. In this study, co-localization with intracellular 
localization marker proteins was investigated to elucidate the endocytic pathway 
of the pancreatic α-amylase. Transferrin (Tf), early endosome antigen-1 (EEA1), 
and lysosomal-associated membrane protein 1 (LAMP1) were used as localization 
marker proteins of the cell membrane, early endosomes, and lysosomes, respec-
tively, and were stained with an Alexa Fluor 594-labeled secondary antibody. 
Alexa Fluor 488-human pancreatic α-amylase (AF488-α-amylase) was mainly 
co-localized with Tf by chasing for 0–5 min at 37°C. Subsequently, the AF488-
α-amylase was co-localized with EEA1 after chasing for 5–10 min, and then the 
α-amylase was finally co-localized with LAMP1 after a 30–60 min chase, followed 
by its disappearance (Figure 5). These results suggested that pancreatic α-amylase 
Figure 5. 
Co-localization between human pancreatic α-amylase and localization marker proteins. Caco-2 cells were 
seeded at 2.6 × 105 cells/cm2 on polyester Transwell permeable supports and cultured for about 3 weeks in 
DMEM supplemented with 20% heat-inactivated FBS and 0.1 mM NEAA under a 95% air and 5% CO2 
atmosphere. The cells were starved in a DMEM-NEAA medium without FBS for 18 h. After being washed 
with DPBS containing Ca2+ and Mg2+, AF488-human pancreatic α-amylase (20 μg/ml) and/or Alexa Fluor 
594 (AF594)-Tf in a DMEM-NEAA medium without FBS were added, and cells were incubated at 4°C for 
30 min. The α-amylase was washed out, and cells were cultured in DMEM including 20% FBS and 1 mM 
NEAA at 37°C for 0–60 min. After the cells were fixed, they were stained with an anti-EEA1 antibody or 
anti-LAMP1 antibody as the first antibody, and followed by AF594-labeled secondary antibodies. The nucleus 
was stained by DAPI. The three kinds of fluorescence were detected by confocal microscopy (ZEISS, LSM710) 
(A) [25]. These weighted colocalizations were calculated as described previously [25] (B).
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Figure 6. 
A hypothetical schematic of the biological function of pancreatic α-amylase internalization.
binds to the cell membrane and is transported into lysosomes though early endo-
somes and the α-amylase undergo degradation in the lysosome. The disappearance 
of AF488-amylases endocytosed into the cells was suppressed by chloroquine, 
which is an inhibitor of lysosome proteolysis (data not shown) [25]. In another 
experiment using pig duodenum tissue sections, α-amylase in the duodenum was 
well co-localized with LAMP1, and its degraded fragments were detected (data 
not shown) [25]. These results indicate that pancreatic α-amylase internalized 
by the endocytic pathway is undergoing proteolysis in the lysosome. Degraded 
α-amylase may be used as a source for rapid turnover in duodenal epithelial cells.
4.3 Biological significances of endocytosis of pancreatic α-amylase
Based on the SGLT1 inhibition of pancreatic α-amylase described in Section 
3.2, the biological significance of endocytosis of the pancreatic α-amylase in 
Sections 4.1 and 4.2 is discussed as follows. Figure 6 shows a hypothetical 
scheme of the biological function of α-amylase internalization [25]. (i) Within 
30 min after food intake, pancreatic α-amylase has begun to be secreted from 
the pancreas into the duodenum, but its amount is not high. Therefore, the 
α-amylase on the surface of the duodenal BBM interacts with the SI on the BBM 
to promote starch digestion by both the α-amylase and SI. (ii) Approximately 
30 min after food intake, the concentration of pancreatic α-amylase in the small 
intestinal lumen reaches a maximum, and the α-amylase binds to the glyco-
proteins in the BBM. At this time, the glucose uptake of SGLT1 is inhibited by 
the α-amylase, whereby rapid glucose uptake is suppressed, and postprandial 
hyperglycemia is corrected. (iii) At 30–60 min after food intake, the α-amylase 
bound to the BBM is internalized into early endosomes in the epithelial cells. 
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That is, the inhibition of glucose uptake of SGLT1 in BBM by α-amylase is 
released, which means the blood glucose level can be maintained even when 
the blood glucose level drops during fasting. (iv) At 60 min or more after food 
ingestion, the α-amylase internalized into cells is transported to lysosomes and 
undergoes degradation.
5. Expression of endogenous α-amylase in the human duodenum
α-Amylase is abundantly expressed in the pancreas and salivary glands, and 
has been detected in liver [26], thyroid [27], parotid gland [28], white blood 
cells [29], lung carcinoma tissues [30], and brain [3] in humans. There are five 
isoforms of α-amylase including three salivary α-amylases (isoforms AMY1A, 
AMY1B, and AMY1C) and two pancreatic α-amylases (isoforms AMY2A and 
AMY 2B) [31]. The α-amylases in liver, white blood cells, and lung carcinoma 
tissues are encoded by AMY2B [2, 29, 30]. The brain amylases are encoded by 
AMY1A and AMY2B [3]. The parotid gland amylase is encoded by AMY1C [28]. 
It is reported that α-amylase activity is detected in small intestinal tissues [32]. 
It is not clear whether this α-amylase is an exogenous one that endocytoses pan-
creatic α-amylase into small intestinal tissues or an endogenous α-amylase that 
is expressed in the small intestine itself. An endogenous α-amylase was stained 
in differentiated Caco-2 cells by immunostaining with an anti-α-amylase 
antibody during the experiments on internalization using fluorescence-labeled 
α-amylase in the cells described in Section 4. In this study, we demonstrated 
the expression of endogenous α-amylase in human duodenal epithelial cells and 
identified the isoform of the α-amylase expressed in the duodenal epithelial 
cells. Furthermore, the biological significances of α-amylase expression in the 
duodenum are shown [33].
Figure 7. 
Expression of α-amylase in human tissues. A reaction mixture was prepared by mixing Human MTC panel 
I, II or Digestive system MTC panel (Clontech) as a cDNA (5 μl), Power SYBER Green PCR Master mix 
(6.25 μl), 50 μM forward and reverse primers for AMY2B (0.2 μl each), and putting it in the 96-well reaction 
plate. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the internal standard. The sequences 
of primer sets for AMY2B and GAPDH were described previously [33]. Normalized data by GAPDH are 
shown with liver expression as 1.
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Figure 8. 
Expression of α-amylase in differentiated human epithelial cells. Caco-2 cells were seeded at 5 × 104 cells/cm2 
in the wells and cultured for 3 weeks in DMEM supplemented with 20% heat-inactivated FBS and 0.1 mM 
NEAA under a 95% air and 5% CO2 atmosphere. The cells were washed with DPBS and were prepared for 
each measurement as described previously [33]. (A) mRNA expression of α-amylase in the cells was measured 
by quantitative real-time PCR using a 7500 Real-Time PCR System (Applied Biosystems). *p < 0.05, **p < 0.01, 
***p < 0.001 vs. Day 2 by one-way ANOVA with Dunnett’s posthoc test. (B) Protein levels of α-amylase in the 
cell extract were detected by Western blotting using anti-human pancreatic α-amylase antibody (HPA IgGs) as 
a first antibody and HRP-labeled secondary antibodies. The staining was developed by 3,3′-diaminobenzidine 
(DAB) including H2O2. (C) Specific enzymatic activities of α-amylase in the culture medium and cell extract. 
*p < 0.05, **p < 0.01 vs. medium by paired t-test (D) Immunofluorescence staining of the permeabilized cells 
with anti-HPA IgGs as a first antibody and AF488-labeled secondary antibodies. The nucleus was stained by 
DAPI. The fluorescence was detected by confocal microscopy (ZEISS, LSM710). The lower right is an enlarged 
view [33].
5.1 Expression of AMY2B in human duodenum tissues
The mRNA expression of α-amylase in human tissues was measured by real-
time PCR using human Multiple Tissue cDNA (MTC) Panels. The α-amylase was 
shown to be expressed most in the pancreas and then in the duodenum (Figure 7). 
The results mean that the α-amylase detected in the duodenum consists of both the 
endogenous α-amylase expressed in the duodenum and the exogenous α-amylase 
expressed by the pancreas and internalized into the duodenum. For further inves-
tigation, mRNA levels, protein levels, enzyme activities, and localization of the 
α-amylases were clarified using differentiated Caco-2 cells [33]. Caco-2 cells were 
originally human intestinal epithelial cells derived from the colon, but are known 
to gradually develop small intestine-like properties when differentiated by long-
term culture for about 3 weeks. Therefore, we focused on the change in α-amylase 
expression in Caco-2 cells during differentiation into small intestine-like cells. The 
expression of α-amylase in Caco-2 cells increased with differentiation into small 
intestine-like cells in its mRNA level, protein level, enzyme activity, and immunos-
taining (Figure 8). Activity of α-amylase was detected in the cell extract but not 
in the culture medium, suggesting that the α-amylase was not secreted by the cells 
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(Figure 8C). Immunostaining showed that the α-amylase in the cytoplasm was 
localized in a dotted pattern (Figure 8D). The isotype of the α-amylase expressed in 
differentiated Caco-2 cells was identified as pancreatic type AMY2B by a combina-
tion of PCR and restriction enzyme treatment (data not shown) [33].
5.2 Biological significances of α-amylase expressed in the duodenum
α-Amylase has been shown to be expressed by tissues other than the pancreas 
and salivary glands, but the biological significance has not been elucidated. The 
increased α-amylase expression in obese mouse liver suggests that liver α-amylase 
may be a biomarker for obesity [34]. It has been hypothesized that α-amylase 
expressed in the brain may be an energy source in Alzheimer’s disease [3]. Here, it 
was shown that the expression of α-amylase by Caco-2 cells was suppressed by RNA 
interference (RNAi), and affected cell proliferation and differentiation [33]. The 
expression of α-amylase was suppressed to about 30% by siRNA (small interfering 
RNA), and four kinds of cell differentiation markers were quantified by real-time 
PCR. All four differentiation markers were reduced in cells transfected with 
α-amylase siRNA compared to cells transfected with control siRNA (Figure 9A). 
This result indicates that α-amylase expression is required for cell differentiation. 
Furthermore, it was shown that the cell proliferation of cells transfected with 
α-amylase siRNA was dramatically reduced depending on the cell-seeding concen-
tration (Figure 9B).
6. Conclusion
This study showed new functions of both exogenous and endogenous pan-
creatic α-amylase other than starch digestion in the small intestine. Exogenous 
α-amylase synthesized by the pancreas and secreted into the small intestinal tract 
enhances α-glucosidase activity and inhibits glucose uptake by SGLT1 in the small 
Figure 9. 
Effects of α-amylase suppression by siRNA on cell differentiation and proliferation. Nonspecific siRNA as a 
control or the siRNA targeting α-amylase was transfected to Caco-2 cells and these cells were seeded at 2 × 105 
cells/cm2 (A) or 1 × 105 cells/cm2 (B) in the wells. The cells were cultured for 3 days in DMEM supplemented 
with 20% heat-inactivated FBS and 0.1 mM NEAA under a 95% air and 5% CO2 atmosphere. (A) The 
cells were washed with DPBS and were prepared for mRNA expression as described previously [33]. mRNA 
expressions of α-amylase differentiation marker proteins (SI, DPP-4, E-cadherin, villin) in the cells were 
measured by quantitative real-time PCR using a 7500 Real-Time PCR System (Applied Biosystems). (B) The 
cells in the 96-well plates were stained with MTT, and the cell viability was measured by an MTT assay. Mock, 
the cells transfected with the transfection reagent only without siRNA. Data are shown as mean ± SE, *p < 0.05, 
**p < 0.01, ***p < 0.001, one-way ANOVA with Tukey’s posthoc test [33].
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intestine BBM. The exogenous α-amylase was internalized into lysosomes and 
degraded in intestinal epithelial cells. On the other hand, endogenous α-amylase 
is highly expressed in the duodenum, where it enhances cell proliferation and 
differentiation.
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